# A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)

> **NCT00294008** · — · COMPLETED · sponsor: **Janssen Korea, Ltd., Korea** · enrollment: 230 (actual)

## Conditions studied

- Schizophrenia
- Tranquilizing Agents
- Mental Disorders
- Therapeutic Uses
- Physiological Effects of Drugs
- Psychotropic Drugs
- Antipsychotic Agents

## Interventions

- **DRUG:** Risperdal Consta

## Key facts

- **NCT ID:** NCT00294008
- **Lead sponsor:** Janssen Korea, Ltd., Korea
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2014-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00294008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00294008, "A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00294008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*